IN2009KN04098A - - Google Patents
Download PDFInfo
- Publication number
- IN2009KN04098A IN2009KN04098A IN4098KON2009A IN2009KN04098A IN 2009KN04098 A IN2009KN04098 A IN 2009KN04098A IN 4098KON2009 A IN4098KON2009 A IN 4098KON2009A IN 2009KN04098 A IN2009KN04098 A IN 2009KN04098A
- Authority
- IN
- India
- Prior art keywords
- component
- lyophilised
- lyophilised meningococcal
- reconstitute
- reconstituted
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93323507P | 2007-06-04 | 2007-06-04 | |
| PCT/IB2008/002121 WO2008149238A2 (en) | 2007-06-04 | 2008-06-04 | Formulation of meningitis vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2009KN04098A true IN2009KN04098A (de) | 2015-08-28 |
Family
ID=40094241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN4098KON2009 IN2009KN04098A (de) | 2007-06-04 | 2008-06-04 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20100203137A1 (de) |
| EP (1) | EP2152302B1 (de) |
| JP (1) | JP5637848B2 (de) |
| CN (1) | CN101678094B (de) |
| AU (2) | AU2008259423A1 (de) |
| BR (1) | BRPI0811979A2 (de) |
| CA (1) | CA2688268A1 (de) |
| ES (1) | ES2555786T3 (de) |
| IN (1) | IN2009KN04098A (de) |
| MX (1) | MX2009013112A (de) |
| NZ (1) | NZ581367A (de) |
| RU (1) | RU2009149359A (de) |
| WO (1) | WO2008149238A2 (de) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2261355A3 (de) | 1998-05-01 | 2012-01-11 | Novartis Vaccines and Diagnostics, Inc. | Antigene und Zusammensetzungen gegen Neisseria meningitidis |
| CN102580072A (zh) | 1999-05-19 | 2012-07-18 | 诺华疫苗和诊断有限公司 | 组合式奈瑟球菌组合物 |
| CA2864069A1 (en) | 1999-10-29 | 2001-05-03 | Novartis Vaccines And Diagnostics S.R.L. | Neisserial antigenic peptides |
| DK1790660T3 (da) | 2000-02-28 | 2012-09-17 | Novartis Vaccines & Diagnostic | Heterolog ekspression af Neisseria-proteiner |
| SK288007B6 (sk) * | 2000-06-29 | 2012-10-02 | Glaxosmithkline Biologicals S. A. | Multivalent vaccine composition, process for its producing, and its use |
| GB0118249D0 (en) | 2001-07-26 | 2001-09-19 | Chiron Spa | Histidine vaccines |
| GB0121591D0 (en) | 2001-09-06 | 2001-10-24 | Chiron Spa | Hybrid and tandem expression of neisserial proteins |
| MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
| GB0227346D0 (en) | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
| GB0408977D0 (en) | 2004-04-22 | 2004-05-26 | Chiron Srl | Immunising against meningococcal serogroup Y using proteins |
| US9931397B2 (en) | 2005-06-27 | 2018-04-03 | Glaxosmithkline Biologicals S.A. | Immunogenic composition |
| GB0524066D0 (en) | 2005-11-25 | 2006-01-04 | Chiron Srl | 741 ii |
| EP2462949A3 (de) * | 2007-10-19 | 2012-09-05 | Novartis AG | Meningokokkenimpfstoffformulierungen |
| US9579372B2 (en) | 2008-02-21 | 2017-02-28 | Glaxosmithkline Biologicals Sa | Meningococcal fHBP polypeptides |
| AU2009268937A1 (en) * | 2008-06-16 | 2010-01-14 | Aj Park | Compositions for inducing immune responses specific to Globo H and SSEA3 and uses thereof in cancer treatment |
| GB0822634D0 (en) | 2008-12-11 | 2009-01-21 | Novartis Ag | Meningitis vaccines |
| JP5668049B2 (ja) * | 2009-03-24 | 2015-02-12 | ノバルティス アーゲー | 髄膜炎菌ｈ因子結合タンパク質および肺炎球菌糖結合体の組み合わせ |
| EP2411048B1 (de) * | 2009-03-24 | 2020-05-06 | GlaxoSmithKline Biologicals SA | Adjuvantierendes meningokokken-faktor-h-bindungsprotein |
| CN101590225B (zh) * | 2009-06-19 | 2012-02-15 | 长春长生生物科技股份有限公司 | 百白破、A+C群脑膜炎球菌-b型流感嗜血杆菌结合疫苗 |
| EP2585106A1 (de) | 2010-06-25 | 2013-05-01 | Novartis AG | Kombinationen aus meningokokken-faktor-h-bindenden proteinen |
| HRP20210242T4 (hr) | 2010-08-23 | 2024-05-10 | Wyeth Llc | Stabilne formulacije antigena iz bakterije neisseria meningitidis rlp2086 |
| CN103096920B (zh) | 2010-09-10 | 2016-03-23 | 惠氏有限责任公司 | 脑膜炎奈瑟球菌orf2086抗原的非脂质化变体 |
| RU2013131795A (ru) * | 2010-12-10 | 2015-01-20 | Мерк Шарп Энд Домэ Корп. | Новые композиции, которые уменьшают вызываемую встряхиванием агрегацию иммуногенных композиций |
| US9283270B2 (en) * | 2012-01-20 | 2016-03-15 | Serum Institute Of India Ltd. | Method for stabilization of biological molecules |
| CA2866406A1 (en) * | 2012-03-08 | 2013-09-12 | Novartis Ag | Adjuvanted formulations of booster vaccines |
| SA115360586B1 (ar) | 2012-03-09 | 2017-04-12 | فايزر انك | تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها |
| BR122016004924A2 (pt) | 2012-03-09 | 2019-07-30 | Pfizer Inc. | Polipeptídeo isolado e composições imunogênicas compreendendo os mesmos |
| EP2861247B1 (de) | 2012-06-14 | 2020-12-09 | GlaxoSmithKline Biologicals SA | Impfstoffe gegen serogruppe-x-meningokokken |
| JP6446377B2 (ja) | 2013-03-08 | 2018-12-26 | ファイザー・インク | 免疫原性融合ポリペプチド |
| CA2923129C (en) | 2013-09-08 | 2020-06-09 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| AU2016221318B2 (en) | 2015-02-19 | 2020-06-25 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| MX2019002489A (es) | 2016-09-02 | 2019-10-21 | Sanofi Pasteur Inc | Vacuna contra neisseria meningitidis. |
| AU2018215585B2 (en) | 2017-01-31 | 2022-03-17 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5153312A (en) | 1990-09-28 | 1992-10-06 | American Cyanamid Company | Oligosaccharide conjugate vaccines |
| US5425946A (en) | 1992-08-31 | 1995-06-20 | North American Vaccine, Inc. | Vaccines against group C Neisseria meningitidis |
| DK0658118T3 (da) | 1992-08-31 | 2002-05-06 | Baxter Healthcare Sa | Vaccine mod Neisseria meningitidis, gruppe C |
| GB9422096D0 (en) * | 1994-11-02 | 1994-12-21 | Biocine Spa | Combined meningitis vaccine |
| PL184872B1 (pl) | 1995-06-23 | 2003-01-31 | Smithkline Beecham Biolog | Kombinowana szczepionkaĆ zestaw do przygotowania kombinowanej szczepionkiĆ sposób wytwarzania kombinowanej szczepionki i jej zastosowanie |
| US6299881B1 (en) | 1997-03-24 | 2001-10-09 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts |
| SK288007B6 (sk) | 2000-06-29 | 2012-10-02 | Glaxosmithkline Biologicals S. A. | Multivalent vaccine composition, process for its producing, and its use |
| MXPA03006561A (es) | 2001-01-23 | 2004-10-15 | Aventis Pasteur | Vacuna del conjugado proteina-polisacarido meningococico, multivalente. |
| GB0115176D0 (en) * | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
| DK1777236T3 (en) | 2002-03-26 | 2017-02-27 | Glaxosmithkline Biologicals Sa | MODIFIED SUCCARIDES WHICH IMPROVED WATER STABILITY FOR USE AS A MEDICINE |
| EP2191844B1 (de) * | 2003-01-30 | 2014-03-05 | Novartis AG | Injizierbarer Impfstoff gegen multiple Meningokokken-Serogruppen |
| CN103405761A (zh) | 2003-10-02 | 2013-11-27 | 诺华疫苗和诊断有限公司 | 多种脑膜炎球菌血清群的液体疫苗 |
| GB0405787D0 (en) * | 2004-03-15 | 2004-04-21 | Chiron Srl | Low dose vaccines |
| GB0500787D0 (en) * | 2005-01-14 | 2005-02-23 | Chiron Srl | Integration of meningococcal conjugate vaccination |
| GB0409745D0 (en) * | 2004-04-30 | 2004-06-09 | Chiron Srl | Compositions including unconjugated carrier proteins |
| GB0505518D0 (en) * | 2005-03-17 | 2005-04-27 | Chiron Srl | Combination vaccines with whole cell pertussis antigen |
| CN1709505B (zh) * | 2005-07-13 | 2010-06-16 | 北京绿竹生物制药有限公司 | 多价细菌荚膜多糖-蛋白质结合物联合疫苗 |
| JP5135220B2 (ja) * | 2005-09-01 | 2013-02-06 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス ゲーエムベーハー アンド カンパニー カーゲー | 血清群ｃ髄膜炎菌を含む複数ワクチン接種 |
| GB0524066D0 (en) * | 2005-11-25 | 2006-01-04 | Chiron Srl | 741 ii |
| EP2462949A3 (de) * | 2007-10-19 | 2012-09-05 | Novartis AG | Meningokokkenimpfstoffformulierungen |
-
2008
- 2008-06-04 RU RU2009149359/15A patent/RU2009149359A/ru not_active Application Discontinuation
- 2008-06-04 AU AU2008259423A patent/AU2008259423A1/en not_active Abandoned
- 2008-06-04 CN CN200880018507.2A patent/CN101678094B/zh not_active Expired - Fee Related
- 2008-06-04 CA CA2688268A patent/CA2688268A1/en not_active Abandoned
- 2008-06-04 JP JP2010510910A patent/JP5637848B2/ja not_active Expired - Fee Related
- 2008-06-04 BR BRPI0811979-1A2A patent/BRPI0811979A2/pt not_active IP Right Cessation
- 2008-06-04 EP EP08789070.3A patent/EP2152302B1/de active Active
- 2008-06-04 MX MX2009013112A patent/MX2009013112A/es active IP Right Grant
- 2008-06-04 NZ NZ581367A patent/NZ581367A/en not_active IP Right Cessation
- 2008-06-04 WO PCT/IB2008/002121 patent/WO2008149238A2/en active Application Filing
- 2008-06-04 US US12/451,831 patent/US20100203137A1/en not_active Abandoned
- 2008-06-04 IN IN4098KON2009 patent/IN2009KN04098A/en unknown
- 2008-06-04 ES ES08789070.3T patent/ES2555786T3/es active Active
-
2014
- 2014-07-15 AU AU2014204425A patent/AU2014204425B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| ES2555786T3 (es) | 2016-01-08 |
| JP5637848B2 (ja) | 2014-12-10 |
| RU2009149359A (ru) | 2011-07-20 |
| AU2014204425B2 (en) | 2015-10-29 |
| CN101678094A (zh) | 2010-03-24 |
| EP2152302A2 (de) | 2010-02-17 |
| US20100203137A1 (en) | 2010-08-12 |
| WO2008149238A3 (en) | 2009-08-06 |
| CN101678094B (zh) | 2014-08-27 |
| BRPI0811979A2 (pt) | 2014-10-21 |
| WO2008149238A2 (en) | 2008-12-11 |
| JP2010529103A (ja) | 2010-08-26 |
| AU2014204425A1 (en) | 2014-08-07 |
| AU2008259423A1 (en) | 2008-12-11 |
| CA2688268A1 (en) | 2008-12-11 |
| EP2152302B1 (de) | 2015-10-07 |
| MX2009013112A (es) | 2010-03-01 |
| NZ581367A (en) | 2012-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2009KN04098A (de) | ||
| MX350285B (es) | Métodos y composiciones para producir hidrocarburos. | |
| WO2014058954A3 (en) | Surgical staple insertion device | |
| IN2012DE00840A (de) | ||
| WO2010067201A3 (en) | MIXING LYOPHILISED MENINGOCOCCAL VACCINES WITH D-T-Pa VACCINES | |
| MX2009011191A (es) | Jeringa ergonomica. | |
| MX347825B (es) | Sistema de sujeción con acoplamiento estable y ajuste de barra. | |
| MX362576B (es) | Cabezal de fracturación ajustable y sistema de colector. | |
| WO2011062987A3 (en) | Methods and compositions for producing hydrocarbons | |
| GB201211058D0 (en) | Fuel system | |
| MX2010001842A (es) | Sistemas y metodos para calcular un modelo de variograma. | |
| WO2011109481A3 (en) | Decorative element for medical devices | |
| WO2013106798A3 (en) | Method and apparatus for generating a privilege-based key | |
| NZ595223A (en) | Combinations including pneumococcal serotype 14 saccharide | |
| WO2011162959A3 (en) | Generating recommendations for improving a presentation document | |
| WO2014000106A8 (en) | User-selectable ieee 1588 clock class and quality level mapping | |
| WO2013096127A3 (en) | Plug and abandonment system | |
| CA2865777A1 (en) | 2,2',6,6'-tetraisopropyl-4,4'-biphenol lipid microsphere preparations and preparation methods therefor | |
| JP2015102367A5 (de) | ||
| MX2011008619A (es) | Bebida a base de coco, no lactea. | |
| WO2012010862A3 (en) | Improved combustible composition | |
| MX2010013103A (es) | Ciclo termodinamico con unidad de potencia y venturi y un metodo para producir un efecto util con el mismo. | |
| UA35566U (ru) | Способ введения первого троакара в брюшную полость при лапароскопической холецистэктомии | |
| Neakrase | Terrestrial Analogs for Venusian Dunes: Sub-Aqueous, Seafloor Dune Fields | |
| 森田俊朗 | ASAJ |